
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 96.580 | 96.580 | 0.000 |
Bonds | 4.240 | 4.240 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.109 | 20.203 |
Price to Book | 3.135 | 4.125 |
Price to Sales | 2.134 | 2.474 |
Price to Cash Flow | 16.598 | 16.541 |
Dividend Yield | 1.203 | 1.363 |
5 Years Earnings Growth | 13.014 | 12.131 |
Number of long holdings: 66
Number of short holdings: 8
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 5.86 | 476.57 | +2.04% | |
Medincell | FR0004065605 | 5.39 | 14.08 | -2.63% | |
Eli Lilly | US5324571083 | 4.06 | 916.00 | -1.48% | |
Boston Scientific | US1011371077 | 3.15 | 104.21 | -0.63% | |
Becton Dickinson | US0758871091 | 3.06 | 225.32 | -1.37% | |
Merck&Co | US58933Y1055 | 2.87 | 92.85 | -0.32% | |
Novartis | CH0012005267 | 2.51 | 99.38 | +0.47% | |
Thermo Fisher Scientific | US8835561023 | 2.48 | 517.54 | -1.16% | |
Fresenius SE | DE0005785604 | 2.28 | 39.410 | +0.46% | |
UCB | BE0003739530 | 2.24 | 195.05 | +1.48% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 120.48M | 4.67 | -8.39 | - | ||
Pluvalca France Small Caps A | 85.98M | 2.67 | -3.07 | 4.79 | ||
Pluvalca Initiatives PME A | 69.9M | 2.29 | -7.74 | 7.19 | ||
Pluvalca Allcaps A | 57.69M | 6.79 | 2.13 | 6.02 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review